Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7540605

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-01-01 to
2023-09-30
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-01-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
711,294,000 JPY
1,386,748,000 JPY
1,095,607,000 JPY
Ordinary profit (loss)
-1,203,335,000 JPY
-1,278,820,000 JPY
-735,543,000 JPY
Profit (loss) attributable to owners of parent
-1,230,344,000 JPY
-1,349,539,000 JPY
-795,218,000 JPY
Comprehensive income
-1,196,293,000 JPY
-1,331,861,000 JPY
-718,777,000 JPY
Net assets
3,816,618,000 JPY
3,641,844,000 JPY
3,943,268,000 JPY
Total assets
4,192,236,000 JPY
4,266,453,000 JPY
4,547,738,000 JPY
Basic earnings (loss) per share
-20.13
-73.74
-99.10
-31.92
-58.56
Diluted earnings per share
Equity-to-asset ratio
0.910 xbrli:pure
0.850 xbrli:pure
0.865 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.